Chris Snyder, a Non-Resident Senior Fellow at the Institute for Progress and an economics professor at Dartmouth, dives deep into Advanced Market Commitments (AMCs). He discusses the unexpected collaboration of the U.S. and Russia in funding innovations. Snyder reveals why certain diseases like malaria didn't get AMCs, while cancer and Alzheimer’s may be poor candidates. He explores the complexities of vaccine funding and the vital role of organizations like the Gates Foundation in enhancing vaccine distribution, emphasizing the need for a balanced approach to health challenges.